Foggi P - Search Results

1

Early market access of cancer drugs in the EU.

Martinalbo J, Bowen D, Camarero J, Chapelin M, Démolis P, Foggi P, Jonsson B, Llinares J, Moreau A, O'Connor D, Oliveira J, Vamvakas S, Pignatti F. Martinalbo J, et al. Among authors: foggi p. Ann Oncol. 2016 Jan;27(1):96-105. doi: 10.1093/annonc/mdv506. Epub 2015 Oct 20. Ann Oncol. 2016. PMID: 26487583 Free article. Review.

2

Reply to the letter to the editor 'Number-Needed-To-Treat for pricing costly anti-cancer drugs. The example of Regorafenib in metastatic colorectal cancer' by Graziano et al.

Pignatti F, Martinalbo J, Jonsson B, Foggi P. Pignatti F, et al. Among authors: foggi p. Ann Oncol. 2016 May;27(5):958. doi: 10.1093/annonc/mdw049. Epub 2016 Feb 9. Ann Oncol. 2016. PMID: 26861599 Free article. No abstract available.

3

European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer.

Stanel SC, Sjöberg J, Salmonson T, Foggi P, Caleno M, Melchiorri D, Gravanis I, Tzogani K, Pignatti F. Stanel SC, et al. Among authors: foggi p. ESMO Open. 2017 May 2;2(2):e000190. doi: 10.1136/esmoopen-2017-000190. eCollection 2017. ESMO Open. 2017. PMID: 28761750 Free PMC article. Review.

4

A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.

Vici P, Brandi M, Giotta F, Foggi P, Schittulli F, Di Lauro L, Gebbia N, Massidda B, Filippelli G, Giannarelli D, Di Benedetto A, Mottolese M, Colucci G, Lopez M. Vici P, et al. Among authors: foggi p. Ann Oncol. 2012 May;23(5):1121-1129. doi: 10.1093/annonc/mdr412. Epub 2011 Sep 28. Ann Oncol. 2012. PMID: 21965475 Free PMC article. Clinical Trial.

5

A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.

Vici P, Di Lauro L, Sergi D, Foggi P, Viola G, Mottolese M, Giotta F, Fattoruso SI, Corsetti S, Giannarelli D, Botti C, Lopez M. Vici P, et al. Among authors: foggi p. Oncology. 2008;75(3-4):175-81. doi: 10.1159/000163056. Epub 2008 Oct 8. Oncology. 2008. PMID: 18841031 Clinical Trial.

6

Docetaxel in patients with anthracycline-resistant advanced breast cancer.

Vici P, Belli F, Di Lauro L, Amodio A, Conti F, Foggi P, Gionfra T, Morelli MF, Botti C, Ferraironi A, Lopez M. Vici P, et al. Among authors: foggi p. Oncology. 2001;60(1):60-5. doi: 10.1159/000055298. Oncology. 2001. PMID: 11150910 Clinical Trial.

7

Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.

Vici P, Foggi P, Colucci G, Capomolla E, Brandi M, Giotta F, Gebbia N, Di Lauro L, Valerio MR, Paoletti G, Belli F, Pizza C, Giannarelli D, Lopez M. Vici P, et al. Among authors: foggi p. Anticancer Res. 2005 Mar-Apr;25(2B):1309-14. Anticancer Res. 2005. PMID: 15865083 Free article. Clinical Trial.

8

Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

Vici P, Giotta F, DI Lauro L, Brandi M, Gebbia V, Foggi P, Lorusso V, Vitucci C, Sergi D, Fattoruso SI, Giannarelli D, Viola G, Corsetti S, Colucci G, Lopez M. Vici P, et al. Among authors: foggi p. Anticancer Res. 2009 May;29(5):1841-5. Anticancer Res. 2009. PMID: 19443414 Free article. Clinical Trial.

9

[Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer].

Fattoruso SI, Rossi S, Vici P, Di Filippo F, Botti C, Di Lauro L, Foggi P, Saracca E, Ferranti FR, Visca P, Lopez M. Fattoruso SI, et al. Among authors: foggi p. Clin Ter. 2008 Nov-Dec;159(6):443-7. Clin Ter. 2008. PMID: 19169606 Review. Italian.

10

Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.

Vici P, Viola G, Botti C, Rossi S, Vitucci C, Corsetti S, Di Lauro L, Sergi D, Foggi P, Perri P, Tirelli C, Mottolese M, Fattoruso SI, Lopez M. Vici P, et al. Among authors: foggi p. Clin Ter. 2008 Nov-Dec;159(6):449-52. Clin Ter. 2008. PMID: 19169607 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters